A John Orwin

Affiliations

  • at Anaptysbio Inc (ANAB), 2025-06-17
  • at Travere Therapeutics Inc. (TVTX), 2025-05-16
  • at Cargo Therapeutics Inc. (CRGX), 2024-06-06
  • President & Ceo at Atreca Inc. (BCEL), 2024-04-17
  • at Seagen Inc. (SGEN), 2023-12-15
  • Director at Array Biopharma Inc (ARRY), 2019-07-31
  • President & Ceo at Relypsa Inc (RLYP), 2016-09-02
  • Director at Affymax Inc (AFFY), 2013-06-28
  • Director at Neurogesx Inc (NGSX), 2012-06-12
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BCEL $0.01 1 $0.01 1 2024-04-11 Filing
BCEL $12.79 6,000 $76,740.00 6,000 2020-03-17 Filing
SGEN $28.33 2,000 $56,660.00 10,700 2016-02-12 Filing
RLYP $11.00 15,000 $165,000.00 15,000 2013-11-20 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BCEL $0.37 22,951 $8,597.44 77,541 2023-09-01 Filing
BCEL $1.78 20,908 $37,115.88 100,492 2022-09-02 Filing
RLYP $29.67 800 $23,732.64 54,375 2015-12-07 Filing
RLYP $28.52 7,379 $210,450.56 55,175 2015-12-07 Filing
RLYP $27.85 6,821 $189,949.16 62,554 2015-12-07 Filing